Skip to main content

Advertisement

SpringerLink
Log in

Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aims to demonstrate the effect of omega-3 fatty acids (ω-3 FAs) supplements on the clinical manifestations, laboratory investigations, disease activity, functional capacity, response criteria as well as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) levels in juvenile idiopathic arthritis (JIA) patients. Twenty-seven JIA patients were included in this study. Dietary supplements of ω-3 FAs 2 g/day were given for 12 weeks. Juvenile arthritis disease activity score in 27 joints (JADAS-27) and pediatric American College of Rheumatology (ACR) response criteria were determined. Childhood Health Assessment Questionnaire (CHAQ) was used to measure the functional status. Assessment of serum IL-1 and TNF-α level was performed using enzyme-linked immunosorbent assay. The mean age of the patients was 12.78 ± 3.26 years, the disease duration was 5.93 ± 3.06 years, and the age at disease onset was 6.78 ± 3.26 years. The TNF-α and IL-1 were significantly higher in the JIA patients compared to the control. There was a significant improvement of active joint count, number of swollen joints, JADAS-27, CHAQ, TNF-α, and IL-1 levels. The pediatric ACR response criteria improved in 92.59% of the patients. The daily requirements of nonsteroidal anti-inflammatory drugs (NSAIDs) obviously decreased. ω-3 FAs supplements reduce the inflammatory response and improve the clinical manifestation in JIA patient. The daily intake of NSAID dose decreased thus reducing the risk of related side effects. Our results support the use of omega-3 fatty acids as an add-on therapy to conventional treatment of JIA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390–392

    PubMed  Google Scholar 

  2. Hinks A, Ke X, Barton A et al (2009) Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 60(1):251–257

    Article  PubMed  CAS  Google Scholar 

  3. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201(9):1479–1486

    Article  PubMed  CAS  Google Scholar 

  4. Wong SC, MacRae VE, Gracie JA, McInnes IB, Galea P, Gardner-Medwin J, Ahmed SF (2008) Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis. Growth Horm IGF Res 18(5):369–378

    Article  PubMed  CAS  Google Scholar 

  5. Pain CE, McCann LJ (2009) Challenges in the management of juvenile idiopathic arthritis with etanercept. Biologics 3:127–139

    PubMed  CAS  Google Scholar 

  6. Kris-Etherton PM, Taylor DS, Yu-Poth S et al (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71(1 Suppl):179S–188S, Review

    PubMed  CAS  Google Scholar 

  7. Freeman LM (2010) Beneficial effects of omega-3 fatty acids in cardiovascular disease. J Small Anim Pract 51(9):462–470

    Article  PubMed  Google Scholar 

  8. Sales C, Oliviero F, Spinella P (2008) Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases. Reumatismo 60(2):95–101

    PubMed  CAS  Google Scholar 

  9. Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658–666

    Article  PubMed  Google Scholar 

  10. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40(7):1202–1209

    PubMed  CAS  Google Scholar 

  11. Singh G, Athreya BH, Fries JF, Goldsmith DP (1994) Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 37(12):1761–1769

    Article  PubMed  CAS  Google Scholar 

  12. Chan EJ, Cho L (2009) What can we expect from omega-3 fatty acids? Cleve Clin J Med 76(4):245–251

    Article  PubMed  Google Scholar 

  13. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE (2006) Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 83(6 Suppl):1483S–1493S

    PubMed  CAS  Google Scholar 

  14. Hosseini SA, Rahim F, Mola K (2009) Omega-3 induced changes in clinical parameters of rheumatoid arthritis. J Med Sci 9(2):93–97

    Article  Google Scholar 

  15. Maroon JC, Bost JW (2006) Omega-3 fatty acids (fish-oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 65(4):326–331

    Article  PubMed  Google Scholar 

  16. Arita M, Bianchini F, Aliberti J et al (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201(5):713–722

    Article  PubMed  CAS  Google Scholar 

  17. Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH (1998) Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum 27(6):366–367

    Article  PubMed  CAS  Google Scholar 

  18. Kremer JM, Lawrence DA, Petrillo GF et al (1995) Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs clinical and immune correlates. Arthritis Rheum 38(8):1107–1114

    Article  PubMed  CAS  Google Scholar 

  19. Foeldvari I, Nielsen S, Kümmerle-Deschner J et al (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34(5):1146–1150

    PubMed  CAS  Google Scholar 

  20. Chu AJ, Walton MA, Prasad JK, Seto A (1999) Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells. J Surg Res 87(2):217–224

    Article  PubMed  CAS  Google Scholar 

  21. Riediger ND, Othman RA, Suh M, Moghadasian MH (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109(4):668–679

    Article  PubMed  CAS  Google Scholar 

  22. Adam O, Fasse S, Ditrich O (2009) Diet in rheumatic disease. Z Rheumatol 68(7):549–558

    Article  PubMed  CAS  Google Scholar 

  23. Bays HE (2007) Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 99(6A):S35–43C

    Article  Google Scholar 

  24. Vargová V, Veselý R, Sasinka M, Török C (1998) Will administration of omega-3 unsaturated fatty acids reduce the use of non steroidal antirheumatic agents in children with chronic juvenile arthritis? J Cas Lek Cesk 137(21):651–653

    Google Scholar 

  25. Fantuzzi G, Di Santo E, Sacco S, Benigni F, Ghezzi G (1995) Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. Effect of stress and inhibition of endogenous glucocorticoids. The Journal of Immunology 155(7):3552–3555

    PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Rheumatology Department, Faculty of Medicine, Cairo University, Giza, Egypt

    Tamer Gheita & Sahar Kamel

  2. Chemical Pathology Department, National Research Centre, Giza, Egypt

    Nabila El-Laithy

  3. Child Health Department, National Research Centre, Giza, Egypt

    Neveen Helmy & Amira Monir

Authors
  1. Tamer Gheita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sahar Kamel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neveen Helmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nabila El-Laithy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amira Monir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tamer Gheita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gheita, T., Kamel, S., Helmy, N. et al. Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria. Clin Rheumatol 31, 363–366 (2012). https://doi.org/10.1007/s10067-011-1848-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1848-5

Keywords

Search

Navigation